New York City health officials scrambled to explain themselves Thursday following outraged media reports about bankers who got scarce H1N1 flu vaccines through their employers

A new study says doctors should be especially vigilant about people who are over 50 with flu symptoms because they appear to have a higher risk of death from H1N1.

The director of the FDA's division of antiviral products is urging caution in the use of a new flu drug that just won special permission to fight H1N1.

Dendreon has completed its U.S. regulatory submission for its closely watched experimental prostate cancer vaccine, the company said Monday, sending its shares up 5 percent.

A large study being published in a major medical journal says certain kidney disease patients who get the drug Aranesp to treat anemia-related fatigue may be at greater risk of having a stroke.

Stocks rallied Thursday, rebounding off of the prior session's rout, after reports showed the economy grew more than expected last quarter and jobless claims fell. The Dow jumped more than 2 percent—its best day since July.

Stocks rallied Thursday, rebounding off of the prior session's rout, after reports showed the economy grew more than expected last quarter and jobless claims fell.

Stocks rallied Thursday, rebounding off of the prior session's rout, after reports showed the economy grew more than expected last quarter and jobless claims fell.

Futures pointed to a positive open for Wall Street on Thursday ahead of the all-important U.S. third-quarter gross domestic product data.

Stocks tumbled to session lows late Wednesday, with the Dow down more than 100 points, as worries about the recovery gripped the market.

Stocks were lower at the halfway point Wednesday as investors shrugged off some good news and worries about the recovery gripped the market.

Stocksskidded Wednesday, despite a rise in durable-goods orders and some earnings beats, as worries about the recovery dragged on the market.

The weak consumer confidence report that hit U.S. stocks on Tuesday is having a lingering effect this Wednesday, with global stock markets falling and stock index futures pointing to another lower open on Wall Street.

GlaxoSmithKline has yet to get U.S. government approval for its swine flu vaccine, the company said Tuesday, while Novartis said it was still struggling to make vaccines.

U.S. President Barack Obama has declared 2009 H1N1 swine flu a national emergency, the White House said Saturday.